Nuveen Churchill Direct Lending Corp.
Business
Nuveen Churchill Direct Lending Corp. is a specialty finance company that invests primarily in senior secured loans to private equity‑owned U.S. middle market companies. It offers directly originated first‑lien senior secured loans and unitranche loans, and opportunistically provides junior capital, subordinated debt, equity co‑investments and related credit instruments. The firm is externally managed with portfolio management delegated to Churchill Asset Management and a liquid investment allocation managed by Nuveen Asset Management under sub‑advisory arrangements. Its investments are focused on U.S. middle market companies sourced through private equity sponsor relationships and institutional and wealth distribution channels.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Payment-in-kind interest income | 10 | 8 | 4 | 789,000 | 113,000 | |
| Dividend income | 402,000 | 614,000 | 101,000 | 225,000 | 213,000 | |
| Other income | 2 | 2 | 1 | 2 | 1 | |
| Interest and debt financing expenses | 78 | 80 | 61 | 26 | 10 | |
| Management fees (See Note 6) | 19 | 15 | 11 | 7 | 4 | |
| Incentive fees on net investment income (See Note 6) | 11 | 17 | 0 | — | — | |
| Professional fees | 3 | 3 | 3 | 2 | 1 | |
| Directors' fees | 624,000 | 510,000 | 383,000 | 383,000 | 383,000 | |
| Administration fees (See Note 6) | 2 | 2 | 2 | 1 | 660,000 | |
| Other general and administrative expenses | 2 | 1 | 751,000 | 684,000 | 324,000 | |
| Total expenses before expense support and incentive fees waived | 117 | 119 | 78 | 37 | 17 | |
| Expense support (See Note 6) | 0 | 0 | −158,000 | −179,000 | −522,000 | |
| Incentive fees waived (See Note 6) | −2 | −17 | 0 | — | — | |
| Net expenses after expense support and incentive fees waived | 114 | 101 | 78 | 37 | 16 | |
| Net investment income before excise taxes | 94 | 123 | 84 | 45 | 20 | |
| Excise taxes | 186,000 | 551,000 | 6,000 | 0 | 0 | |
| Net investment income | 93 | 122 | 84 | 45 | 20 | |
| Net realized gain (loss) on non-controlled/non-affiliated company investments | −6 | −13 | −8 | −262,000 | 819,000 | |
| Non-controlled/non-affiliated company investments | −22 | 7 | 714,000 | −28 | 6 | |
| Income tax (provision) benefit | — | −154,000 | −830,000 | — | — | |
| Net increase (decrease) in net assets resulting from operations | 66 | 116 | 76 | 17 | 27 | |
| Net investment income per share - basic (in dollars per share) | 1.86 | 2.26 | 2.52 | 1.95 | 1.58 | |
| Net investment income per share - diluted (in dollars per share) | 1.86 | 2.26 | 2.52 | 1.95 | 1.58 | |
| Net increase (decrease) in net assets resulting from operations per share - basic and diluted (in dollars per share) | 1.3 | 2.15 | 2.27 | 0.74 | 2.12 | |
| Weighted average common shares outstanding - basic (in shares) | 50 | 54 | 33 | 23 | 12,849 | |
| Weighted average common shares outstanding - diluted (in shares) | 50 | 54 | 33 | 23 | 12,849 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-09-30 | FY 2024 2024-06-30 | FY 2024 2024-03-31 |
|---|---|---|---|---|---|---|
| Non-controlled/non-affiliated company investments, at fair value (cost of $2,001,207 and $2,098,575, respectively) | 1,962 | 2,081 | — | — | — | |
| Cash | 9 | 2 | — | — | — | |
| Cash equivalents | 54 | 41 | — | — | — | |
| Restricted cash | 0 | 50,000 | — | — | — | |
| Interest receivable | 14 | 18 | — | — | — | |
| Derivative asset, at fair value (Note 4) | 15 | 0 | — | — | — | |
| Receivable for investments sold | 518,000 | 1 | — | — | — | |
| Other assets | 327,000 | 47,000 | — | — | — | |
| Total assets | 2,054 | 2,144 | — | — | — | |
| Debt (net of $8,511 and $6,668 deferred financing costs, respectively, and net of unamortized discount of $471 and $0, respectively) (See Note 7) | 1,115 | 1,108 | — | — | — | |
| Payable for investments purchased | 0 | 15 | — | — | — | |
| Interest payable | 15 | 13 | — | — | — | |
| Incentive fees payable | 3 | 0 | — | — | — | |
| Management fees payable | 5 | 4 | — | — | — | |
| Collateral due to broker | 15 | 0 | — | — | — | |
| Distributions payable | 22 | 29 | — | — | — | |
| Directors fees payable | 156,000 | 128,000 | — | — | — | |
| Accounts payable and accrued expenses | 4 | 4 | — | — | — | |
| Total liabilities | 1,179 | 1,173 | — | — | — | |
| Commitments and contingencies (See Note 8) | — | — | — | — | — | |
| Common shares, $0.01 par value, 500,000,000 and 500,000,000 shares authorized, 49,387,065 and 53,387,277 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 494,000 | 534,000 | — | — | — | |
| Paid-in-capital in excess of par value | 930 | 996 | — | — | — | |
| Total distributable earnings (loss) | −56 | −27 | — | — | — | |
| Total net assets | 875 | 970 | — | — | — | |
| Total liabilities and net assets | 2,054 | 2,144 | — | — | — | |
| Net asset value per share (in dollars per share) | 17.72 | 18.18 | 18.15 | 18.03 | 18.21 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Purchases of investments | −351 | −864 | −589 | −502 | −611 | |
| Proceeds from principal repayments and sales of investments | 456 | 430 | 146 | 49 | 181 | |
| Payment-in-kind interest | −10 | −8 | −3 | −789,000 | −112,000 | |
| Amortization of (premium)/accretion of discount, net | −4 | −4 | −3 | −2 | −1 | |
| Net adjustment for hedging transaction | −5 | 0 | 0 | — | — | |
| Amortization of deferred financing costs and original issue discount | 4 | 4 | 2 | — | — | |
| Amortization of offering costs | 0 | 0 | −23,000 | −82,000 | −68,000 | |
| Due from adviser for expense support | 0 | 0 | 1 | 2 | −248,000 | |
| Interest receivable | 4 | −297,000 | −6 | −7 | −3 | |
| Receivable for investments sold | 506,000 | 3 | −3 | 4 | −4 | |
| Prepaid expenses | 0 | −34,000 | 28,000 | 23,000 | −26,000 | |
| Other assets | −280,000 | 127,000 | 0 | 0 | −128,000 | |
| Payable for investments purchased | −15 | 15 | −56,000 | −26 | 26 | |
| Interest payable | 2 | 3 | 1 | 7 | 797,000 | |
| Due to adviser for expense support | 0 | −632,000 | −515,000 | −2 | 248,000 | |
| Incentive fee payable | 3 | 0 | 0 | — | — | |
| Management fees payable | 1 | 950,000 | 795,000 | 835,000 | 848,000 | |
| Collateral due to broker | 15 | 0 | 0 | — | — | |
| Directors fees payable | 28,000 | 32,000 | 0 | 0 | — | |
| Accounts payable and accrued expenses | 248,000 | 863,000 | 206,000 | 2 | 38,000 | |
| Net cash provided by (used in) operating activities | 194 | −297 | −370 | −428 | −389 | |
| Proceeds from issuance of common shares | 0 | 242 | 219 | 175 | 209 | |
| Shareholder distributions | −102 | −95 | −63 | −35 | −15 | |
| Repurchases of common shares | −66 | −34 | 0 | 0 | — | |
| Proceeds from debt | 918 | 884 | 811 | — | — | |
| Repayments on debt | −919 | −721 | −564 | — | — | |
| Payments of deferred financing costs | −6 | −3 | −4 | −3 | −664,000 | |
| Net cash provided by (used in) financing activities | −175 | 273 | 398 | 432 | 412 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 19 | −24 | 28 | 4 | 23 | |
| Cash paid during the period for interest | 72 | 73 | 58 | 18 | 10 | |
| Taxes, including excise tax, paid during the period | 704,000 | 6,000 | 0 | 0 | — | |
| Distributions payable | 22 | 29 | 23 | 14 | — | |
| Reinvestment of shareholder distributions | 0 | 12 | 10 | 3 | 324,000 |